CD19 and leukemia: There is also a possibility that the founder clone could be a cell that has no mature antigen receptor rearrangement (e.g. IGH, IGK-Kde, TCRD, TCRG) rearrangement (CD19−), which was observed in leukaemia cells from t(4;11) pro-B ALL patients [74].